G. Ha, K. Kwong, B. Tanaka, Y. Nishimura, and C. Chong, “Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD”, EJCRIM, vol. 10, no. 7, Jun. 2023.